ISDA MEMBER LOGIN REQUIRED. With Regulatory Technical Standards finalised, firms went live from March 2013 on key requirements under the EU legislation for clearing, trade reporting and the treatment of bilateral transactions (EMIR). This webinar addresses how the requirements affect you, whatever the size and nature of your activity in OTC derivatives. There are sections on the instruments and entities in scope; the varying treatment of financial and non-financial entities (and sovereigns too); and the crucial issue of territorial scope. Also discussed are ISDA’s plans to update documentation to reflect the new regulatory landscape.
Latest
Response to EC Call for Evidence on Tax Omnibus
On March 30, ISDA, the International Securities Lending Association and the Association for Financial Markets in Europe responded to the European Commission’s (EC) call for evidence on the tax omnibus. The associations argue that inconsistent interpretation of “beneficial ownership” among...
Managing Risk for Australian Superannuation Funds
Assets managed by the Australian superannuation sector reached A$4.5 trillion in December 2025, equivalent to around 160% of Australia’s GDP. Given its size, the sector has rapidly expanded its global footprint, with the share of offshore investments growing as a...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.
Next Steps on a Much Improved Basel III Endgame
Publication of the revised Basel III endgame proposal earlier this month marks an important step towards completion of the global capital reforms, giving banks much-needed clarity on the likely calibration of the rules in the US. The new proposal is...